Cargando…
Evaluation of false positives in the SARS-CoV-2 quantitative antigen test
INTRODUCTION: Highly sensitive reagents for detecting SARS-CoV-2 antigens have been developed for accurate and rapid diagnosis till date. In this study, we aim to clarify the frequency of false-positive reactions and reveal their details in SARS-CoV-2 quantitative antigen test using an automated lab...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8226058/ https://www.ncbi.nlm.nih.gov/pubmed/34238663 http://dx.doi.org/10.1016/j.jiac.2021.06.019 |
_version_ | 1783712204003999744 |
---|---|
author | Kobayashi, Ryo Murai, Ryosei Moriai, Mikako Nirasawa, Shinya Yonezawa, Hitoshi Kondoh, Takashi Saeki, Masachika Yakuwa, Yuki Sato, Yuki Katayama, Yuki Nakafuri, Hirotaka Kitayama, Ikumi Asanuma, Koichi Fujiya, Yoshihiro Takahashi, Satoshi |
author_facet | Kobayashi, Ryo Murai, Ryosei Moriai, Mikako Nirasawa, Shinya Yonezawa, Hitoshi Kondoh, Takashi Saeki, Masachika Yakuwa, Yuki Sato, Yuki Katayama, Yuki Nakafuri, Hirotaka Kitayama, Ikumi Asanuma, Koichi Fujiya, Yoshihiro Takahashi, Satoshi |
author_sort | Kobayashi, Ryo |
collection | PubMed |
description | INTRODUCTION: Highly sensitive reagents for detecting SARS-CoV-2 antigens have been developed for accurate and rapid diagnosis till date. In this study, we aim to clarify the frequency of false-positive reactions and reveal their details in SARS-CoV-2 quantitative antigen test using an automated laboratory device. METHODS: Nasopharyngeal swab samples (n = 4992) and saliva samples (n = 5430) were collected. We measured their SARS-CoV-2 antigen using Lumipulse® Presto SARS-CoV-2 Ag and performed a nucleic acid amplification test (NAAT) using the Ampdirect™ 2019 Novel Coronavirus Detection Kit as needed. The results obtained from each detection test were compared accordingly. RESULTS: There were 304 nasopharyngeal samples and 114 saliva samples were positive in the Lumipulse® Presto SARS-CoV-2 Ag test. All positive nasopharyngeal samples in the antigen test were also positive for NAAT. In contrast, only three (2.6%) of all the positive saliva samples in the antigen test were negative for NAAT. One showed no linearity with a dilute solution in the dilution test. Additionally, the quantitative antigen levels of all the three samples did not decrease after reaction with the anti-SARS-CoV-2 antibody. CONCLUSIONS: The judgment difference between the quantitative antigen test and NAAT seemed to be caused by non-specific reactions in the antigen test. Although the high positive and negative predictive value of this quantitative antigen test could be confirmed, we should consider the possibility of false-positives caused by non-specific reactions and understand the characteristics of antigen testing. We recommend that repeating centrifugation before measurement, especially in saliva samples, should be performed appropriately. |
format | Online Article Text |
id | pubmed-8226058 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-82260582021-06-25 Evaluation of false positives in the SARS-CoV-2 quantitative antigen test Kobayashi, Ryo Murai, Ryosei Moriai, Mikako Nirasawa, Shinya Yonezawa, Hitoshi Kondoh, Takashi Saeki, Masachika Yakuwa, Yuki Sato, Yuki Katayama, Yuki Nakafuri, Hirotaka Kitayama, Ikumi Asanuma, Koichi Fujiya, Yoshihiro Takahashi, Satoshi J Infect Chemother Original Article INTRODUCTION: Highly sensitive reagents for detecting SARS-CoV-2 antigens have been developed for accurate and rapid diagnosis till date. In this study, we aim to clarify the frequency of false-positive reactions and reveal their details in SARS-CoV-2 quantitative antigen test using an automated laboratory device. METHODS: Nasopharyngeal swab samples (n = 4992) and saliva samples (n = 5430) were collected. We measured their SARS-CoV-2 antigen using Lumipulse® Presto SARS-CoV-2 Ag and performed a nucleic acid amplification test (NAAT) using the Ampdirect™ 2019 Novel Coronavirus Detection Kit as needed. The results obtained from each detection test were compared accordingly. RESULTS: There were 304 nasopharyngeal samples and 114 saliva samples were positive in the Lumipulse® Presto SARS-CoV-2 Ag test. All positive nasopharyngeal samples in the antigen test were also positive for NAAT. In contrast, only three (2.6%) of all the positive saliva samples in the antigen test were negative for NAAT. One showed no linearity with a dilute solution in the dilution test. Additionally, the quantitative antigen levels of all the three samples did not decrease after reaction with the anti-SARS-CoV-2 antibody. CONCLUSIONS: The judgment difference between the quantitative antigen test and NAAT seemed to be caused by non-specific reactions in the antigen test. Although the high positive and negative predictive value of this quantitative antigen test could be confirmed, we should consider the possibility of false-positives caused by non-specific reactions and understand the characteristics of antigen testing. We recommend that repeating centrifugation before measurement, especially in saliva samples, should be performed appropriately. Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. 2021-10 2021-06-25 /pmc/articles/PMC8226058/ /pubmed/34238663 http://dx.doi.org/10.1016/j.jiac.2021.06.019 Text en © 2021 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Original Article Kobayashi, Ryo Murai, Ryosei Moriai, Mikako Nirasawa, Shinya Yonezawa, Hitoshi Kondoh, Takashi Saeki, Masachika Yakuwa, Yuki Sato, Yuki Katayama, Yuki Nakafuri, Hirotaka Kitayama, Ikumi Asanuma, Koichi Fujiya, Yoshihiro Takahashi, Satoshi Evaluation of false positives in the SARS-CoV-2 quantitative antigen test |
title | Evaluation of false positives in the SARS-CoV-2 quantitative antigen test |
title_full | Evaluation of false positives in the SARS-CoV-2 quantitative antigen test |
title_fullStr | Evaluation of false positives in the SARS-CoV-2 quantitative antigen test |
title_full_unstemmed | Evaluation of false positives in the SARS-CoV-2 quantitative antigen test |
title_short | Evaluation of false positives in the SARS-CoV-2 quantitative antigen test |
title_sort | evaluation of false positives in the sars-cov-2 quantitative antigen test |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8226058/ https://www.ncbi.nlm.nih.gov/pubmed/34238663 http://dx.doi.org/10.1016/j.jiac.2021.06.019 |
work_keys_str_mv | AT kobayashiryo evaluationoffalsepositivesinthesarscov2quantitativeantigentest AT murairyosei evaluationoffalsepositivesinthesarscov2quantitativeantigentest AT moriaimikako evaluationoffalsepositivesinthesarscov2quantitativeantigentest AT nirasawashinya evaluationoffalsepositivesinthesarscov2quantitativeantigentest AT yonezawahitoshi evaluationoffalsepositivesinthesarscov2quantitativeantigentest AT kondohtakashi evaluationoffalsepositivesinthesarscov2quantitativeantigentest AT saekimasachika evaluationoffalsepositivesinthesarscov2quantitativeantigentest AT yakuwayuki evaluationoffalsepositivesinthesarscov2quantitativeantigentest AT satoyuki evaluationoffalsepositivesinthesarscov2quantitativeantigentest AT katayamayuki evaluationoffalsepositivesinthesarscov2quantitativeantigentest AT nakafurihirotaka evaluationoffalsepositivesinthesarscov2quantitativeantigentest AT kitayamaikumi evaluationoffalsepositivesinthesarscov2quantitativeantigentest AT asanumakoichi evaluationoffalsepositivesinthesarscov2quantitativeantigentest AT fujiyayoshihiro evaluationoffalsepositivesinthesarscov2quantitativeantigentest AT takahashisatoshi evaluationoffalsepositivesinthesarscov2quantitativeantigentest |